This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Quidel's CEO Presents At Goldman Sachs Healthcare Conference (Transcript)

Stocks in this article: QDEL

Quidel Corporation (QDEL)

Goldman Sachs Healthcare Conference Call

June 05, 2012 06:20 pm ET

Executives

Doug Bryant - President & CEO

Randy Steward - CFO



Analysts

Isaac Ro - Goldman Sachs

Presentation

Isaac Ro - Goldman Sachs

Thanks everybody for attending. Isaac Ro from Goldman Sachs; I am the Life Science analyst here and certainly happy to have the management team from Quidel here with us today. So you know as with all the other presentations I want to make sure that I will keep it as interactive as possible and so by all means please don't be shy to ask a question. Raise your hand if you like anytime in the conversation and we will be sure of calling you and for those of you on the webcast as well, please feel free to ping me with an email if you want. I am happy to read back your question anonymously of course and we will go from there.

So with that as a backdrop, Doug if you maybe first get everyone situated. There has been a lot of going on at Quidel in evolving the company over the last couple of years and Doug to make sure we get proper context, so if you could spend a few minutes and can give us a background on the company and your key financial goals for this year that will be great.

Doug Bryant

Okay sure, terrific. The company has been around for a while. The history of the company actually is predominantly rapid point of care diagnostic test as early as 1985 we developed and commercialized a pregnancy test fold truly thereafter by a group based prep test. And then in the 1999 we co-developed with Glaxo the first flu assay which has had several iterations to that product. And so for the most part up until about 2008, we for the most part a company that participated very nicely in the rapid point of care diagnostics space. I came on Board in 2009. The Board gave me the mandate of diversifying our product portfolio, developing a broader based diagnostic business, a business that's certainly less dependent on flu. We don't mind the seasonality of flu. We dislike it when we don't see any flu at all.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs